Should Lactobacillus sporogenes and Bacillus coagulans Have a future?

REFERENCES

• Lilly DM, Stillwell RH. Probiotics. Growth promoting factors produced by micro-organisms. Science 1965; 147: 747–748.
   Google Scholar
• Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66: 365–378.
   PubMedGoogle Scholar
• Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol 1998; 39: 237–238.
   PubMed Web of Science ®Google Scholar
• FAO/WHO. Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid nacteria. 2002 Report of a Joint FAO/WHO Expert Con-sultation. Available at: http:www.fao.org/es/ESN/food/foodan-dfoo_probio_en.stm.
   Google Scholar
• Metchnikoff E. The prolongation of life. Optimistic studies. London: Butterworth-Heinemann. 1907.
   Google Scholar
• Döderlain A. Das Scheindensekret und seine Bedeutung fur das Puerperalfieber. Centralblatt Bacteriol 1892; 11: 699–700.
   Google Scholar
• Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2002; 8: 99–110.
   PubMed Web of Science ®Google Scholar
• Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2005; 21: 44–50.
   PubMed Web of Science ®Google Scholar
• Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, et al. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clini-cal trials. Ant Leeuwen 1999; 76: 279–292.
   Google Scholar
• Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr 2001; 73: 11475–11515.
   Google Scholar
• Montrose DC, Floch MH. Probiotics used in human Studies. J Clin Gastroenterol 2005; 39: 469–484.
   PubMed Web of Science ®Google Scholar
• Singhi SC, Baranwal A. Probiotic use in the critically ill. In-dian J Pediatr. 2008; 75: 621–627.
   Web of Science ®Google Scholar
• Goossens D, Jonkers D, Stobberingh E, van den Bogaard A, Russel M, Stockbrugger R. Probiotics in gastroenterology: in-dications and future perspectives. Scand J Gastroenterol Suppl 2003; 239: 15–23.
   PubMedGoogle Scholar
• Szajewska H, Mrukowicz JZ. Use of probiotics in children with acute diarrhea. Paed Drugs 2005; 7: 111–122.
   PubMedGoogle Scholar
• Luyer MD, Buurman WA, Hadfoune M, Speelmans G, Knol J, Jacobs JA et al. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 2005; 73: 3686–3692.
   Google Scholar
• Hamilton-Miller JMT, Shah S, Smith CT. “Probiotic” remedies are not what they seem. Br Med J 1996; 312: 55–56.
   Google Scholar
• Weese SJ. Microbiologic evaluation of commercial prod-ucts. J Am Vet Med Ass 2002; 220: 794–797.
   PubMed Web of Science ®Google Scholar
• Fasoli S, Marzotto M, Rizzotti L, Rossi F, Dellaglio F, Torriani S. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int J Food Microbiol 2003; 82: 59–70.
   PubMed Web of Science ®Google Scholar
• Temmerman R, Pot B, Huys G, Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotics products. Int J Food Microbiol 2003; 81: 1–10.
   PubMed Web of Science ®Google Scholar
• Coeuret V, Gueguen M, Vernoux JP. Numbers and strains of lactobacilli in some probiotic products. Int J Food Microbiol 2004; 97: 147–156.
   PubMed Web of Science ®Google Scholar
• Drago L, De Vecchi E, Nicola L, Colombo A, Gismondo MR. Microbiological evaluation of commercial probiotic products available in Italy. J Chemother 2004; 16: 463–467.
   PubMed Web of Science ®Google Scholar
• De Vecchi E, Drago L. Lactobacillus sporogenes or Bacil-lus coagulans: misidentification or mislabelling? Int J Probiotics Prebiotics 2006; 1: 3-10.
   Google Scholar
• Claus D, Berkeley RCW. 0. Genus Bacillus Cohn 1872. In: Snetah PHA, Mair NS, Sharpe ME, Holt JG, eds. Bergey's Ma-nual of Systematic Bacteriology Baltimore: Williams and Wilkins. 1986: 1105-1139.
   Google Scholar
• Nakamura LK. Phylogeny of Bacillus sphaericus -like or-ganisms. Int J Sys Evol Microbiol 2000; 50: 1715–1722.
   PubMed Web of Science ®Google Scholar
• De Clerck E, Rodriguez-Diaz M, Forsyth, G, Lebbe L, Logan NA, De Vos P. Polyphasic characterization of Bacillus coagulans strains, illustrating heterogeneity within this species, and emended description of the species. Sys Appl Microbiol 2004; 27: 50–60.
   PubMed Web of Science ®Google Scholar
• Anderson RE. Growth and corresponding elevation of tomato juice pH by Bacillus coagulans. J Food Sci 1984; 49: 647–649.
   Web of Science ®Google Scholar
• Cosentino S, Mulargia AE, Pisano B, Tuveri P, Palmas F. Incidence and biochemical characteristics of Bacillus flora in Sar-dinian dairy products. Int J Food Microbiol 1997; 38: 235–238.
   PubMed Web of Science ®Google Scholar
• Ramon-Blanco C, Sanz-Gomez JJ, Lopez-Diaz TM, Otero A, Garcia-Lopez ML. Numbers and species of Bacillus during the manufacture and ripening of Castellano cheese. Milchwis-senschaft - Milk Sci Int 1999; 54: 385–388.
   Google Scholar
• Payot T, Chemaly Z, Fick M. Lactic acid production by Bacillus coagulans-kinetic studies and optimization of culture medium for batch and continuous fermentations. Enz Microb Technol 1999; 24: 191–199.
   Web of Science ®Google Scholar
• Batra N, Singh J, Banerjee UC, Patnaik PR, Sobti RC. Production and characterization of a thermostable beta-galac-tosidase from Bacillus coagulans RCS3. Biotechnol Appl Biochem 2002; 36: 1–6.
   PubMed Web of Science ®Google Scholar
• Yoon HG, Lee KH, Kim HY, Kim HK, Shin DH, Hong BS et al. Gene cloning and biochemical analysis of thermostable chitosanase (Tch-2) from Bacillus coagulans Ck 108. Biosci Biotechnol Biochem 2002; 66: 986–995.
   Google Scholar
• Mc Cartney AL. Application of molecular methods for studying probiotics and the gut. Br J Nutr 2002; 88 (Suppl.1): S29-S37
   Google Scholar
• Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria for probiotic baceria. Am J Clin Nutr 2001; 73 (suppl): 393S-398S.
   Google Scholar
• Adami A, Cavazzoni V. Biomass production, preservation and characteristics of a strain of Bacillus coagulans as probiotic. Microbiol Aliments- Nutr 1993; 11: 93–100.
   Google Scholar
• Hyronimus B, Le Marrec C, Urdaci MC. Coagulin, a bac-teriocin-like inhibitory substance produced by Bacillus coagu-lans. J Appl Microbiol 1998; 85: 42–50.
   PubMed Web of Science ®Google Scholar
• Ciffo F, Da Carro C, Giovannetti M. Gastric resistance of Bacillus subtilis spores used in oral bacteriotherapy: in vitro stu-dies. Farmaci e terapia 1987; 3: 163–169.
   Google Scholar
• Clavel T, Carlin F, Lairon D, Nguyen-The C, Schmitt P. Survival of Bacillus cereus spores and vegetative cells in acid media simulating human stomach. J Appl Microbiol. 2004; 97: 214–9.
   PubMed Web of Science ®Google Scholar
• Salminen S, Isolauri E, Salminen E. Clinical uses of probi-otics for stabilizing the gut mucosal barrier: successful strains and future challenges. Anton Leeuwen 1996; 70: 347–358.
   PubMed Web of Science ®Google Scholar
• Saavedra JM, Bauman N, Oung I, Perman J, Yolken R. Feeding of Bifidobacterium bifidum and Streptococcus ther-mophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 1994; 344: 1046–1049.
   PubMed Web of Science ®Google Scholar
• Adami A, Cavazzoni V. Occurrence of selected bacterial groups in the feces of piglets fed with Bacillus coagulans as probiotic. J Basic Microbiol 1999; 39: 3–9.
   PubMed Web of Science ®Google Scholar
• De Vecchi E, Nicola L, Zanini S, Drago L. In vitro screen-ing of probiotic characteristics of some italian products. J Chemother. 2008; 20: 341–7.
   PubMed Web of Science ®Google Scholar
• Ouwenhand AC. Antimicrobial components from lactic acid bacteria. In Salminen S, von Wright A, eds. Lactic acid bac-teria, microbiology and functional aspects. New York: Marcel Dekker Inc. 1998: 139-160.
   Google Scholar
• Nes IF, Johnsborg 0. Exploration of antimicrobial poten-tial in LAB by genomics. Curr Opin Biotechnol 2004; 15: 100–104.
   PubMed Web of Science ®Google Scholar
• Donskey CJ, Hoyen CK, Das SM, Farmer S, Dery M, Bonomo RA. 0. Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett Appl Microbiol 2001; 33: 84–88.
   Google Scholar
• Wilson KH, Perini F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. In-fect Immun 1988; 56: 2610–2614.
   Web of Science ®Google Scholar
• Sanders ME, Morelli L, Bush S. “Lactobacillus sporo-genes" is not a Lactobacillus probiotic. ASM News 2001; 8: 6.
   Google Scholar
• Cavazzoni V, Adami A, Castrovilli C. Performance of broi-ler chickens supplemented with Bacillus coagulans as probiotic. Brit Poultry Sci 1998; 39: 526–529.
   PubMed Web of Science ®Google Scholar
• Mohan JC, Arora R, Khalilullah M. Short term hypolipi-demic effects of oral Lactobacillus sporogenes therapy in Patients with primary dyslipidemias. Indian Heart J 1990; 42: 361–364.
   PubMedGoogle Scholar
• Mohan JC, Arora R, Khalilullah M. Preliminary observa-tions on effect of Lactobacillus sporogenes on serum lipid lev-els in hypercholesterolemic patients. Indian J Med Res 1990; 92: 431–432.
   PubMed Web of Science ®Google Scholar
• Sanders ME, Morelli L, Tompkins TA. Sporeformers as human probiotics: Bacillus, Sporolattobacillus, and Brevibacil-lus. Compr Rev Food Sci Food Safety 2003; 2: 101–110.
   PubMedGoogle Scholar
• La Rosa M, Bottaro G, Gulino N, Gambuzza F, Di Forti F, ml G et al. 0. Prevention of antibiotic-associated diarrhea with Lactobacillus sporogenes and fructo-oligosaccharides in chil-dren. A multicentric double-blind vs placebo study. Min Pediatr 2003; 55: 447–452.
   Google Scholar
• Astegiano M, Pellicano R, Terzi E, Simondi D, Rizzetto M. Treatment of irritable bowel syndrome. A case control expe-rience. Minerva Gastroenterol Dietol. 2006; 52: 359–363.
   PubMedGoogle Scholar
• Palacios S, Rojo IA, Cancelo MJ, Neyro JL, Castelo-Branco C. Women & apos;s perception of the efficacy of a soy extract with probiotic: the M3 study. Gynecol Endocrinol. 2008; 24: 178–183.
   PubMed Web of Science ®Google Scholar
• Sanders ME. Probiotics: considerations for human health. Nutr Rev 2003; 61: 91–99.
   PubMed Web of Science ®Google Scholar
• Banerjee C, Bustamante Cl, Wharton R, Talley E, Wade JC. Bacillus infections in patients with cancer. Arch Int Med 1988; 148: 1769–1774.
   PubMed Web of Science ®Google Scholar
• Rowan NJ, Caldow G, Gemmell CG, Hunter IS. Produc-tion of diarrheal enterotoxins and other potential virulence factors by veterinary isolates of Bacillus species associated with non-ga-strointestinal infections. Appl Environ Microbiol 2003; 69: 2372–2376.
   PubMed Web of Science ®Google Scholar
• Moldenhauer JE, Bass S, Rubio SL. Antimicrobial resist-ance of three species of Bacillus to thirty various antimicrobial agents.
   Google Scholar
• Hoa TT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S et al. Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gas-trointestinal disorders. Appl Environ Microbiol 2000; 66: 5241–5247.
   Google Scholar
• Casula G, Cutting SM. Bacillus probiotics: spore germi-nation in the gastrointestinal tract. Appl Environ Microbiol 2002; 68: 2344–52.
   PubMed Web of Science ®Google Scholar